本日A2 - M'Koma，阿莫西-白atori, Yasutoshi AU - Ishii, Naoki - Ikeya, Takashi - Takagi, Koichi AU - Nakamura, Kenji AU - Fukuda，Katsuyuki PY - 2020 DA - 2020/06/27 TI -性能状态是改进后的预测因素恶性狭窄患者结肠支架由于Extraparenteral恶性肿瘤SP - 5931341六世- 2020 AB -内镜与self-expandable金属支架支架是被广泛接受的治疗大肠癌的恶性梗阻。一般来说，支架植入术是作为初级结直肠癌(CRC)到手术的桥梁。此外，姑息性结肠支架植入术用于肾外恶性肿瘤(EPMTs)。然而，改善EPMTs结肠支架置入术后临床结果的预测因素仍不清楚。本研究旨在评估EPMTs结肠支架置入术患者，并探讨影响支架置入术后临床改善的因素。21例经EPMTs治疗的结直肠梗阻患者使用自膨胀金属支架长达8年。我们将入组患者分为结肠支架植入术后临床改善组和无改善组。变量,包括年龄;性; type of primary cancer; serum albumin level; location of the obstruction; stent type, length, and diameter; prior chemotherapy treatment; ascites; Eastern Cooperative Oncology Group performance status (PS); technical and clinical success rates; stent-related adverse events; and mortality rates, were evaluated. Technical failure was not observed in all cases. Clinical success, defined as the passage of stool and improvement in the colorectal obstruction scoring system (CROSS) without adverse events, was observed in the 14 patients. Univariate analyses revealed no significant differences in factors other than PS before stenting ( P = 0.04 )在改进组和未改进组之间。结肠支架置入治疗EPMTs是有效的。PS可能是影响支架置入术后临床结果的独立危险因素。SN - 1687-6121 UR - https://doi.org/10.1155/2020/5931341 DO - 10.1155/2020/5931341 JF -胃肠病学研究和实践PB - Hindawi KW - ER -